Canon Medical Research Europe, based in Edinburgh, Scotland, was awarded $180,000 to develop an artificial intelligence (AI)-based medical imaging technology prototype that can recognize, assess and measure asbestos-related cancer tumors, according to a report published Aug. 6 by Scottish Business Insider.